Gov. Tim Walz's "moon shot" proposal for 5,000 daily COVID-19 diagnostic tests in Minnesota appears within reach after the University of Minnesota and Mayo Clinic unveiled aggressive in-state solutions for a global testing shortage.
While contingent on $20 million in state funding, the U on Thursday proposed ramping up its lab capacity in Minneapolis to conduct 10,000 daily molecular tests to diagnose active infections and 10,000 daily serological antibody tests to find people who have recovered.
Walz has called for more in-state testing to track the outbreak before he scales back the current stay-at-home order, which is scheduled to end May 4. The U should be ready then, said Dr. Timothy Schacker, the U medical school's vice dean for research.
"Our aim is to be up and running by that time, for sure," he said.
The two testing types work at opposite ends of the COVID-19 spectrum — with the molecular tests of nasal or throat swabs finding the active presence of the virus, and the serological tests of blood serum finding virus-fighting antibodies after people have recovered. Walz has said both are needed to map the severity and course of the pandemic.
Mayo Clinic's commercial reference lab, the third largest in the country, already had capacity for 7,500 molecular diagnostic tests per day and has been a key resource early in the pandemic. About 25,000 such tests, more than half of the 41,675 performed so far in the state, were done by Mayo.
Now the Rochester, Minn., lab is looking to increase that capacity and double the number of antibody tests — from 10,000 to 20,000 per day — which among other things could be used for surveillance of entire work sites to determine which workers have recovered and are no longer infection risks.
The coronavirus that causes COVID-19 has proved more infectious than expected — with Chinese researchers publishing estimates in Nature Medicine this week that 44% of infections are transmitted before patients have symptoms.